148 related articles for article (PubMed ID: 31995775)
21. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
22. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
[TBL] [Abstract][Full Text] [Related]
23. Arsenic in Dermatology.
Maloney ME
Dermatol Surg; 1996 Mar; 22(3):301-4. PubMed ID: 8599743
[TBL] [Abstract][Full Text] [Related]
24. miR-186 induces tetraploidy in arsenic exposed human keratinocytes.
Ferragut Cardoso AP; Nail AN; Banerjee M; Wise SS; States JC
Ecotoxicol Environ Saf; 2023 May; 256():114823. PubMed ID: 36989553
[TBL] [Abstract][Full Text] [Related]
25. Proteomic profiling reveals candidate markers for arsenic-induced skin keratosis.
Guo Z; Hu Q; Tian J; Yan L; Jing C; Xie HQ; Bao W; Rice RH; Zhao B; Jiang G
Environ Pollut; 2016 Nov; 218():34-38. PubMed ID: 27552035
[TBL] [Abstract][Full Text] [Related]
26. Aberrant immune responses in arsenical skin cancers.
Lee CH; Liao WT; Yu HS
Kaohsiung J Med Sci; 2011 Sep; 27(9):396-401. PubMed ID: 21914527
[TBL] [Abstract][Full Text] [Related]
27. Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion.
Heddle R; Bryant GD
Chest; 1983 Dec; 84(6):776-7. PubMed ID: 6315314
[TBL] [Abstract][Full Text] [Related]
28. An Interaction between Arsenic-Induced Epigenetic Modification and Inflammatory Promotion in a Skin Equivalent during Arsenic Carcinogenesis.
Liao WT; Lu JH; Lee CH; Lan CE; Chang JG; Chai CY; Yu HS
J Invest Dermatol; 2017 Jan; 137(1):187-196. PubMed ID: 27592797
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.
Wu J; Ferragut Cardoso AP; States VAR; Al-Eryani L; Doll M; Wise SS; Rai SN; States JC
Toxicol Appl Pharmacol; 2019 Sep; 378():114614. PubMed ID: 31176655
[TBL] [Abstract][Full Text] [Related]
30. Arsenic mobilizes Langerhans cell migration and induces Th1 response in epicutaneous protein sensitization via CCL21: a plausible cause of decreased Langerhans cells in arsenic-induced intraepithelial carcinoma.
Lee CH; Hong CH; Yu CL; Wang LF; Clausen BE; Liao WT; Huang SK; Chen GS; Yu HS
Biochem Pharmacol; 2012 May; 83(9):1290-9. PubMed ID: 22321510
[TBL] [Abstract][Full Text] [Related]
31. Clonal variability in chromosomal instability as a potential driver in the acquisition of tumorigenic phenotype in chronic arsenic-exposed and hsa-miR-186 overexpressing human keratinocytes.
Lykoudi A; Ferragut Cardoso AP; Wise SS; Banerjee M; States JC
Toxicol Appl Pharmacol; 2023 Nov; 479():116730. PubMed ID: 37866707
[TBL] [Abstract][Full Text] [Related]
32. Pathology related to chronic arsenic exposure.
Centeno JA; Mullick FG; Martinez L; Page NP; Gibb H; Longfellow D; Thompson C; Ladich ER
Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):883-6. PubMed ID: 12426152
[TBL] [Abstract][Full Text] [Related]
33. ΔNp63 promotes abnormal epidermal proliferation in arsenical skin cancers.
Lu JH; Liao WT; Lee CH; Chang KL; Ke HL; Yu HS
Toxicol In Vitro; 2018 Dec; 53():57-66. PubMed ID: 30026126
[TBL] [Abstract][Full Text] [Related]
34. Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes.
Herbert KJ; Holloway A; Cook AL; Chin SP; Snow ET
Toxicol Appl Pharmacol; 2014 Nov; 281(1):136-45. PubMed ID: 25281835
[TBL] [Abstract][Full Text] [Related]
35. Alterations of skin-associated lymphoid tissue in the carcinogenesis of arsenical skin cancer.
Yu HS; Chen GS; Sheu HM; Kao JS; Chang KL; Yu CL
Proc Natl Sci Counc Repub China B; 1992 Jan; 16(1):17-22. PubMed ID: 1385879
[TBL] [Abstract][Full Text] [Related]
36. p53 expression and proliferative activity in Bowen's disease with or without chronic arsenic exposure.
Kuo TT; Hu S; Lo SK; Chan HL
Hum Pathol; 1997 Jul; 28(7):786-90. PubMed ID: 9224745
[TBL] [Abstract][Full Text] [Related]
37. Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure?
Ohnishi Y; Murakami S; Ohtsuka H; Miyauchi S; Shinmori H; Hashimoto K
J Dermatol; 1997 May; 24(5):310-6. PubMed ID: 9198320
[TBL] [Abstract][Full Text] [Related]
38. The mechanistic basis of arsenicosis: pathogenesis of skin cancer.
Hunt KM; Srivastava RK; Elmets CA; Athar M
Cancer Lett; 2014 Nov; 354(2):211-9. PubMed ID: 25173797
[TBL] [Abstract][Full Text] [Related]
39. A case of scrotal superficial basal cell carcinoma caused by chronic arsenic exposure.
Koc E; Arca E; Dincer D; Acikcoz G; Turan Y; Demiriz M
G Ital Dermatol Venereol; 2014 Feb; 149(1):157-9. PubMed ID: 24566581
[No Abstract] [Full Text] [Related]
40. Arsenic-mediated hyperpigmentation in skin via NF-kappa B/endothelin-1 signaling in an originally developed hairless mouse model.
Yajima I; Kumasaka MY; Iida M; Oshino R; Tanihata H; Al Hossain A; Ohgami N; Kato M
Arch Toxicol; 2017 Nov; 91(11):3507-3516. PubMed ID: 28470405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
